Fractional Flow Reserve Versus Angiographically Guided Management to Optimise Outcomes in Unstable Coronary Syndromes
NCT01764334 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 350
Last updated 2017-06-14
Summary
Background: In patients with acute non-ST elevation myocardial infarction (NSTEMI) coronary arteriography is usually recommended however visual interpretation of the coronary angiogram is subjective. A complementary diagnostic approach involves measuring the pressure drop across a coronary stenosis (fractional flow reserve, FFR) with a pressure-sensitive guidewire.
Hypothesis: Routine FFR measurement is feasible in NSTEMI patients and has additive diagnostic, clinical and health economic utility, as compared to angiography-guided standard care.
Design: A prospective multi-center randomized controlled trial in 350 NSTEMI patients with ≥1 coronary stenosis ≥30% severity (threshold for FFR measurement). Patients will be randomized immediately after coronary angiography to the FFR-guided group or angiography-guided group (FFR measured, not disclosed). All patients will then undergo FFR measurement in all vessels with a coronary stenosis ≥30% severity. FFR will be measured in culprit and non-culprit lesions in all patients. FFR will be disclosed to guide treatment in the FFR guided-group but not disclosed in the 'angiography-guided' group. In the FFR-guided group, an FFR\>0.80 will be an indication for medical therapy whereas an FFR≤0.80 will be an indication for revascularization by percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG), as appropriate. The primary endpoint is the between-group difference in the proportion of patients allocated to medical management compared to revascularization. A key secondary composite outcome is the occurrence of cardiac death or hospitalization for myocardial infarction or heart failure. Other secondary outcomes include quality of life, hospitalization for unstable angina, coronary revascularization or stroke, and healthcare costs. Exploratory analyses will also assess the relationships between FFR and angiographic lesion characteristics (severity, culprit status). The minimum and average follow-up periods for the primary analysis are 6 and 18 months respectively. A secondary analysis with longer term follow-up (minimum 3 years) is planned. Screen failures who gave informed consent will be entered into a registry.
Importance: Our developmental clinical trial will address the feasibility of FFR measurement in NSTEMI and the influence of FFR disclosure on treatment decisions and health and economic outcomes.
Conditions
- NonST Elevation Myocardial Infarction
- Myocardial Infarction
Interventions
- DEVICE
-
Fractional flow reserve
Guidewire-based coronary pressure measurement of myocardial FFR can identify obstructive coronary lesions in patients with stable coronary disease, and potentially, medically stabilized patients with recent MI. The FFR index is measured by a conventional coronary wire (0.014") with a pressure sensor on its distal tip during coronary hyperemia induced by intravenous or intracoronary adenosine. The potential diagnostic and prognostic benefit of guidewire-based coronary pressure measurement to inform the management and treatment of patients with recent acute NSTEMI will be assessed.
Sponsors & Collaborators
-
British Heart Foundation
collaborator OTHER -
Abbott Medical Devices
collaborator INDUSTRY -
University of Glasgow
collaborator OTHER -
NHS National Waiting Times Centre Board
lead OTHER
Principal Investigators
-
Colin Berry, MD PhD · University of Glasgow
-
Robert Henderson, MD FRCP · Nottingham University Hospitals, Nottingham, UK
-
Ian Ford, PhD · Robertson Centre for Biostatistics - University of Glasgow
-
Andrew Briggs, PhD · Health Economics and Health Technology Assessment, University of Glasgow
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2014-06-30
- Completion
- 2020-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Clinical Usefulness of Fractional Flow Reserve Measurement for Significant Stenosis in Proximal Coronary Artery
NCT02475291 ·Status: COMPLETED
-
Validation of a Predictive Model of Coronary Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis
NCT03054324 ·Status: UNKNOWN
-
Correlation of FFR CT With Invasive FFR in Multi-ethnic Cohort- a Retrospective Study
NCT06790836 ·Status: RECRUITING
-
Routine Versus Selective Use of FFR to Guide PCI
NCT02000661 ·Status: TERMINATED ·Phase: PHASE4
-
Assessing the Efficacy of CARDIOgoniometry (CGM) to Determine Physiologically Significant Stenosis in Patients With Stable Coronary Artery Disease in Comparison to Fractional FLOW Reserve - CARDIOFLOW
NCT02815631 ·Status: COMPLETED ·Phase: NA
-
Study of the Natural History of FFR Guided Percutaneous Coronary Intervention
NCT01366404 ·Status: RECRUITING
-
Angiogram Based Fractional Flow Reserve in Patients With Multi-Vessel Disease
NCT03455244 ·Status: COMPLETED
-
Influence of FFR on the Clinical Outcome After Percutaneous Coronary Intervention
NCT01873560 ·Status: COMPLETED
-
Evaluation of Diagnostic Accuracy, Safety, and Cost-Effectiveness of the Non-Invasive Cardiolens FFR-CT Pro Method to Measure the Fractional Flow Reserve in Diagnostics of Chronic Coronary Syndromes Versus the Standard Diagnostic Modalities.
NCT04777513 ·Status: COMPLETED
-
Implication of Coronary Artery Disease Burden and Pattern in Ischemia-causing Vessels With PCI
NCT04665466 ·Status: COMPLETED
-
Angiography-derived FFR GPS in Predicting Post-PCI Physiological and Clinical Outcomes
NCT05496023 ·Status: UNKNOWN
-
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
NCT02053038 ·Status: UNKNOWN ·Phase: NA
-
Comparison of the Diagnostic Performance and Costs of FFRB Vs. Standard Care in Suspected Coronary Artery Disease.
NCT06681584 ·Status: ACTIVE_NOT_RECRUITING
-
FFR or OCT Guidance to RevasculariZe Intermediate Coronary Stenosis Using Angioplasty
NCT01824030 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Implication of 3-vessel Fractional Flow Reserve (FFR)
NCT01621438 ·Status: UNKNOWN
-
Evaluation of Accuracy of CFD-based RuiXin-FFR by Comparing With Pressure-wire-based FFR
NCT04731285 ·Status: COMPLETED
-
Angio-based Fractional Flow Reserve to Predict Adverse Events After Stent Implantation
NCT02811796 ·Status: COMPLETED
-
Effect of FFRCT-angio in Functional Diagnosis of Coronary Artery Stenosis
NCT04493086 ·Status: UNKNOWN
-
INTegrated Assessment of intERmediate Coronary Stenoses by Fractional Flow rEserve (FFR) and Near-infraREd Spectroscopy (NIRS)
NCT02985112 ·Status: UNKNOWN
-
Observational Study of OCT in a Patients Undergoing FFR
NCT01663896 ·Status: COMPLETED
-
Safety of Negative FrActional Flow Reserve in Patients With ChallEnging Lesions
NCT02590926 ·Status: COMPLETED
-
Computed Tomography-derived Fractional Flow Reserve vs. Angiographic Quantitative Flow Ratio in Management of Patients With Coronary Artery Disease
NCT07308496 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fractional Flow Reserve (FFR) Stability in Non-Culprit Vessels at ST Elevation Myocardial Infarction(STEMI)
NCT01065103 ·Status: COMPLETED ·Phase: NA
-
Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography
NCT01233518 ·Status: COMPLETED ·Phase: NA
-
Validation of Stenosis Assessment by Coronary Artery Computed Tomography Against Invasive Measurements of Fractional Flow Reserve in Patients With Significant Coronary Artery Stenoses
NCT00817102 ·Status: COMPLETED ·Phase: NA